Document is current
Any future updates will be listed below
-
Authors
Shi, Zhuojun
Li, Site
Chen, Wei
Yan, Hong
-
Funding
Funding for this research was provided by:
Luzhou Southwest Medical University (2021LZXNYD-D06, 2021LZXNYD-D06, 2021LZXNYD-D06)
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 16 April 2025
First Online: 28 April 2025
Declarations
:
: The authors declare no competing interests.
: In accordance with the “Good Clinical Practice for Pharmaceutical Trials” issued by the National Medical Products Administration of the People’s Republic of China and the ethical principles of the “Declaration of Helsinki,” our research protocol has been approved by the ethics review committee of Puyang Renji Hospital composed of 15 experts and the approval number is (PYRJYY-20220701).
: All authors give consent for its publication in Scientific Reports.
